Abstract GS1-03: [Fam-] trastuzumab deruxtecan (T-DXd; DS-8201a) in subjects with HER2-positive metastatic breast cancer previously treated with T-DM1: A phase 2, multicenter, open-label study (DESTINY-Breast01)

• Published in: Cancer Research Vol. 80; pp. GS1 - 03
• Main Authors: Neelima Denduluri, Seock-Ah Im, Yoshinori Ito, Javier Cortes, Keun Seok Lee, Ian E. Krop, Hiroji Iwata, Sung-Bae Kim, Kenji Tamura, Antoine Yver, Sara A. Hurvitz, Caleb Lee, Lin Zhang, Junji Tsurutani, Joohyuk Sohn, Shanu Modi, Eriko Tokunaga, Yeon Hee Park, Christophe Perrin, Toshinari Yamashita, Kenjiro Aogi, Javad Shahidi, Shuquan Chen, Fabrice Andre, Cristina Saura
• Format: Journal Article
• Language: Japanese
• Published: American Association for Cancer Research (AACR) 15.02.2020